Specific meningoencephalitis in patients with transplanted kidney
Main Article Content
Abstract
We described a case of specific (tuberculous) encephalitis in a patient after kidney transplantation. Immunosuppressive therapy, continuously required in post-tranplant period, may cause various complications, such as infections. Specific meningoencephalitis is an infection that is rarely diagnosed and more common in immunocompromised patients.
Case report: A 30-year-old man had kidney transplantation (kidney donor was his father). He previously was two years on chronic hemodialysis treatment because of end-stagerenal disease based on diabetic nephropathy. He has diabetes type 1. The early post-transplant period duly passed with satisfactory clinical and laboratory parameters of renal function. Two months after transplantation, he presented with febrile condition, signs of septicemia and dehydration with significant neurological deficit and expressed meningeal signs. In cerebrospinal fluid we found lymphocytosis, elevated proteins and positive micobacterium tuberculosis antibodies (Hexagon method) and we suspected to specific etiology of meningitis. Performed computed tomography (CT) scan of the brain with contrast confirmed the expected finding.
Due to the poor prognosis of infections of the central nervous system (CNS) in immunocompromised patients, only prompt diagnosis can improve survival in this group of patients. The therapeutic protocol after kidney transplantation include the prophylactic use of antituberculous drug (Isoniazid 300 mg) during the 9 months.
Article Details
Copyright (c) 2020 Tabakovic M, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
Permission to read and download | ✓ |
Permission to display in a repository | ✓ |
Permission to translate | ✓ |
Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Cohen J, Hopkin J, Kurtz J. Infectious complications after renal transplantation. In: Morris PJ (ed). Kidney Transplantation; Principles and Practice. WB Saunders Company, Philadelphia, London, New York, Toronto. 2002; 468-490.
Živčić-Ćosić S, Trobonjača Z, Rački S. Imunosupresivno liječenje kod presađivanja bubrega. Medicina. 2010; 4: 413-23.
Campbell PM. Pathology of acute rejection in the renal allograft. ASHI quaterly. Third quarter. New Jersey: ASHI. 2004: 86.
Ležaić V, Radivojević D, Blagojević R, Đukanović LJ. Infection of central nervous system after kidney transplantation. Transplant Infect Dis 2002; 4: 167-168.
Kidney Disease. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9 (Suppl 3): S1-155. PubMed: https://pubmed.ncbi.nlm.nih.gov/19845597/
Brennan DC, Bohl D. Infectious complications in renal transplant recipients. In: Malluche HH, Sawaya BP, Hakim RM, Sayegh MH (eds). Clinical nephrology, dialysis and transplantation. 2004; 1-34.
Randhawa P, Brennan DC. BK virus infection in transplant recipients: An overview and update. Am J Transplant. 2006; 6: 2000-2005. PubMed: https://pubmed.ncbi.nlm.nih.gov/16771813
Ležaić V, Radivojević R, Radosavljević R, Blagojević R, Simić S, et al. Does tuberculosis after kidney transplantation follows the trend of tuberculosis in general population? Renal Failure. 2001; 23: 97-106. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11256535
Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid organ transplant recipients: impact and implications for menagement. Clin Infect Dis. 2008; 27: 1266-1277.
Morath C, Schmied B, Mehrabi A, Weitz J, Schmidt J, et al. Simultaneous pancreas-kidney transplantation in type 1 diabetes. Clin Transplant. 2009; 23 Suppl 21: 115-20. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19930324
Joyce AT, Iacoviello JM, Nag S. End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care. 2004; 27: 2829-2835. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15562193